Skip to main content
SpringerLink
Log in

DARPP-32 (Ppp1r1b)

  • Reference work entry
  • First Online:
Book cover Encyclopedia of Signaling Molecules

  • 101 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 4,499.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 4,499.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abdolahi A, Acosta G, Breslin FJ, Hemby SE, Lynch WJ. Incubation of nicotine seeking is associated with enhanced protein kinase A-regulated signaling of dopamine- and cAMP-regulated phosphoprotein of 32 kDa in the insular cortex. Eur J Neurosci. 2010;31(4):733–41.

    Article  PubMed  PubMed Central  Google Scholar 

  • Abrahao KP, Oliveira GF, Souza-Formigoni MLO. Individual differences in ethanol locomotor sensitization are associated with dopamine D1 receptor intra-cellular signaling of DARPP-32 in the nucleus accumbens. PLoS One. 2014;9(2):e98296.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Albert KA, Hemmings HC, Adamo AIB, Potkin SG, Akbarian S, Sandman CA, et al. Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia. Arch Gen Psychiatry. 2002 Aug;59(8):705–12.

    Article  CAS  PubMed  Google Scholar 

  • Andersson M, Usiello A, Borgkvist A, Pozzi L, Dominguez C, Fienberg AA, et al. Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons. J Neurosci Off J Soc Neurosci. 2005;25(37):8432–8.

    Article  CAS  Google Scholar 

  • Baracskay KL, Haroutunian V, Meador-Woodruff JH. Dopamine receptor signaling molecules are altered in elderly schizophrenic cortex. Synapse. 2006;60(4):271–9.

    Article  CAS  PubMed  Google Scholar 

  • Belkhiri A, Dar AA, Zaika A, Kelley M, El-Rifai W. t-Darpp promotes cancer cell survival by up-regulation of Bcl2 through Akt-dependent mechanism. Cancer Res. 2008;68(2):395–403.

    Article  CAS  PubMed  Google Scholar 

  • Belkhiri A, Zhu S, El-Rifai W. DARPP-32: from neurotransmission to cancer. Oncotarget. 2016;7(14):17631–40.

    Article  PubMed  PubMed Central  Google Scholar 

  • Benderska N, Becker K, Girault JA, Becker CM, Andreadis A, Stamm S. DARPP-32 binds to tra2-beta1 and influences alternative splicing. Biochim Biophys Acta Gene Regul Mech. 2010;1799(5–6):448–53.

    Article  CAS  Google Scholar 

  • Beuten J, Ma JZ, Lou XY, Payne TJ, Li MD. Association analysis of the protein phosphatase 1 regulatory subunit 1B (PPP1R1B) gene with nicotine dependence in European- and African-American smokers. Am J Med Genet B Neuropsychiatr Genet. 2007;144(3):285–90.

    Article  CAS  Google Scholar 

  • Björk K, Terasmaa A, Sun H, Thorsell A, Sommer WH, Heilig M. Ethanol-induced activation of AKT and DARPP-32 in the mouse striatum mediated by opioid receptors. Addict Biol. 2010;15(3):299–303.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Bodetto SP, Carouge D, Fonteneau M, Dietrich JB, Zwiller J, Anglard P. Cocaine represses protein phosphatase-1Cβ through DNA methylation and methyl-CpG binding protein-2 recruitment in adult rat brain. Neuropharmacology. 2013;73:31–40.

    Article  CAS  Google Scholar 

  • Bonoiu A, Supriya DM, Ling Y, Rajiv K, Hong D, Ken-Tye Y, et al. MMP-9 gene silencing by a quantum dot-siRNA nanoplex delivery to maintain the integrity of the blood brain barrier. Brain Res. 2009;1282:142–155.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Borgkvist A, Marcellino D, Fuxe K, Greengard P, Fisone G. Regulation of DARPP-32 phosphorylation by Δ9-tetrahydrocannabinol. Neuropharmacology. 2008;54(1):31–5.

    Article  CAS  PubMed  Google Scholar 

  • Cardno AG, Holmans PA, Rees MI, Jones LA, Mccarthy GM, Hamshere ML, et al. Rapid publication A genomewide linkage study of age at onset in schizophrenia. Am J Med Genet. 2001;445:439–45.

    Article  Google Scholar 

  • Cash R, Raisman R, Ploska A, Agid Y. Dopamine D-1 receptor and cyclic AMP-dependent phosphorylation in Parkinson’s disease. J Neurochem. 1987;49(4):1075–83.

    Article  CAS  PubMed  Google Scholar 

  • Cathala A, Devroye C, Maitre M, Piazza PV, Abrous DN, Revest JM, et al. Serotonin 2C receptors modulate dopamine transmission in the nucleus accumbens independently of dopamine release: behavioral, neurochemical and molecular studies with cocaine. Addict Biol. 2015;20(3):445–57.

    Article  CAS  PubMed  Google Scholar 

  • Chen J-C, Chen P-C, Chiang Y-C. Molecular mechanisms of psychostimulant addiction. Chang Gung Med J. 2008;32(2):148–54.

    CAS  Google Scholar 

  • Chiapponi C, Piras F, Piras F, Caltagirone C, Spalletta G. GABA system in schizophrenia and mood disorders: a mini review on third-generation imaging studies. Front Psychol. 2016;7:61.

    Google Scholar 

  • Clinton SM, Ibrahim HM, Frey KA, Davis KL, Haroutunian V, Meador-Woodruff JH. Dopaminergic abnormalities in select thalamic nuclei in schizophrenia: involvement of the intracellular signal integrating proteins calcyon and spinophilin. Am J Psychiatr. 2005;162(10):1859–71.

    Article  PubMed  Google Scholar 

  • Cui Y, Prabhu V, Nguyen T, Yadav B, Chung Y-C. The mRNA expression status of dopamine receptor D2, dopamine receptor D3 and DARPP-32 in T lymphocytes of patients with early psychosis. Int J Mol Sci. 2015 Nov;16(11):26677–86.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • ĆurČić-Blake B, Swart M, Ter Horst GJ, Langers DRM, Kema IP, Aleman A. Variation of the gene coding for DARPP-32 (PPP1R1B) and brain connectivity during associative emotional learning. NeuroImage. 2012;59(2):1540–50.

    Article  CAS  PubMed  Google Scholar 

  • Dick DM, Foroud T, Flury L, Bowman ES, Miller MJ, Rau NL, et al. Genomewide linkage analyses of bipolar disorder: a new sample of 250 pedigrees from the National Institute of Mental Health Genetics Initiative. Am J Hum Genet. 2003;73(1):107–14.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Ehrman LA, Williams MT, Schaefer TL, Gudelsky GA, Reed TM, Fienberg AA, et al. Phosphodiesterase 1B differentially modulates the effects of methamphetamine on locomotor activity and spatial learning through DARPP32-dependent pathways: evidence from PDE1B-DARPP32 double-knockout mice. Genes Brain Behav. 2006;5(7):540–51.

    Article  CAS  PubMed  Google Scholar 

  • El-Rifai W, Smith MF, Li G, Beckler A, Carl VS, Montgomery E, et al. Gastric cancers overexpress DARPP-32 and a novel isoform, t-DARPP. Cancer Res. 2002;62(14):4061–4.

    CAS  PubMed  Google Scholar 

  • Engmann O, Giralt A, Gervasi N, Marion-Poll L, Gasmi L, Filhol O, et al. DARPP-32 interaction with adducin may mediate rapid environmental effects on striatal neurons. Nat Commun. 2015;6:10099.

    Article  PubMed  CAS  Google Scholar 

  • Feldcamp LA, Souza RP, Romano-Silva M, Kennedy JL, Wong AHC. Reduced prefrontal cortex DARPP-32 mRNA in completed suicide victims with schizophrenia. Schizophr Res. 2008;103(1–3):192–200.

    Article  PubMed  Google Scholar 

  • Fernández-Ruiz J, Hernández M, Ramos JA. Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders. CNS Neurosci Ther. 2010;16:e72–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fienberg AA, Greengard P. The DARPP-32 knockout mouse. Brain Res Rev. 2000;31(2–3):313–9.

    Article  CAS  PubMed  Google Scholar 

  • Fienberg AA, Hiroi N, Mermelstein PG, Song W, Snyder GL, Nishi A, et al. DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science. 1998; 281(5378):838–42.

    Article  CAS  PubMed  Google Scholar 

  • Frank MJ, Moustafa AA, Haughey HM, Curran T, Hutchison KE. Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learning. Proc Natl Acad Sci. 2007;104(41):16311–6.

    Article  PubMed  PubMed Central  Google Scholar 

  • Fukui R, Svenningsson P, Matsuishi T, Higashi H, Nairn AC, Greengard P, et al. Effect of methylphenidate on dopamine/DARPP signalling in adult, but not young, mice. J Neurochem. 2003;87(6):1391–401.

    Article  CAS  PubMed  Google Scholar 

  • Girault JA, Raisman-Vozari R, Agid Y, Greengard P. Striatal phosphoproteins in Parkinson disease and progressive supranuclear palsy. Proc Natl Acad Sci U S A. 1989;86(7):2493–7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Goodman A. Neurobiology of addiction. An integrative review. Biochem Pharmacol. 2008;75(1):266–322.

    Article  CAS  PubMed  Google Scholar 

  • Greengard P. The neurobiology of dopamine signaling. Biosci Rep. 2001;21:247–69.

    Article  CAS  PubMed  Google Scholar 

  • Guitart X, Nestler EJ. Chronic administration of lithium or other antidepressants increases levels of DARPP-32 in rat frontal cortex. J Neurochem. 1992;59(3):1164–7.

    Article  CAS  PubMed  Google Scholar 

  • Hämmerer D, Biele G, Müller V, Thiele H, Nürnberg P, Heekeren HR, et al. Effects of PPP1R1B (DARPP-32) polymorphism on feedback-related brain potentials across the life span. Front Psychol. 2013;4:89.

    Article  PubMed  PubMed Central  Google Scholar 

  • Hettinger JA, Liu X, Hudson ML, Lee A, Cohen IL, Michaelis RC, et al. DRD2 and PPP1R1B (DARPP-32) polymorphisms independently confer increased risk for autism spectrum disorders and additively predict affected status in male-only affected sib-pair families. Behav Brain Funct. 2012;8:19.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Heyser CJ, Fienberg AA, Greengard P, Gold LH. DARPP-32 knockout mice exhibit impaired reversal learning in a discriminated operant task. Brain Res. 2000;867(1–2):122–30.

    Article  CAS  PubMed  Google Scholar 

  • Host L, Dietrich JB, Carouge D, Aunis D, and Zwiller J. Cocaine self-administration alters the expression of chromatin-remodelling proteins; modulation by histone deacetylase inhibition. J Psychopharmacol. 2011; 25(2):222–9.

    Article  CAS  PubMed  Google Scholar 

  • Ignatowski TA, Aalinkeel R, Reynolds JL, Nair BB, Sykes DE, Gleason CPK, et al. Nanotherapeutic approach for opiate addiction using DARPP-32 gene silencing in an animal model of opiate addiction. J NeuroImmune Pharmacol. 2015;10(1):136–52.

    Article  CAS  PubMed  Google Scholar 

  • Ishikawa M, Mizukami K, Iwakiri M, Asada T. Immunohistochemical and immunoblot analysis of Dopamine and cyclic AMP-regulated phosphoprotein, relative molecular mass 32,000 (DARPP-32) in the prefrontal cortex of subjects with schizophrenia and bipolar disorder. Prog Neuro-Psychopharmacol Biol Psychiatry. 2007;31(6):1177–81.

    Article  CAS  Google Scholar 

  • Kunii Y, Yabe H, Wada A, Yang Q, Nishiura K, Niwa S. Altered DARPP-32 expression in the superior temporal gyrus in schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry. 2011a;35(4):1139–43.

    Article  CAS  Google Scholar 

  • Kunii Y, Ikemoto K, Wada A, Yang Q, Kusakabe T, Suzuki T, et al. Detailed DARPP-32 expression profiles in postmortem brains from patients with schizophrenia: an immunohistochemical study. Med Molecul Morphol. 2011b;44(4):190–9.

    Article  CAS  Google Scholar 

  • Kunii Y, Hyde TM, Ye T, Li C, Kolachana B, Dickinson D, et al. Revisiting DARPP-32 in postmortem human brain: changes in schizophrenia and bipolar disorder and genetic associations with t-DARPP-32 expression. Mol Psychiatry. 2014a;19(2):192–9.

    Article  CAS  PubMed  Google Scholar 

  • Kunii Y, Miura I, Matsumoto J, Hino M, Wada A, Niwa S, et al. Elevated postmortem striatal t-DARPP expression in schizophrenia and associations with DRD2/ANKK1 polymorphism. Prog Neuro-Psychopharmacol Biol Psychiatry. 2014b;53:123–8.

    Article  CAS  Google Scholar 

  • Kuroiwa M, Hamada M, Hieda E, Shuto T, Sotogaku N, Flajolet M, et al. Muscarinic receptors acting at pre- and post-synaptic sites differentially regulate dopamine/DARPP-32 signaling in striatonigral and striatopallidal neurons. Neuropharmacology. 2012;63(7):1248–57.

    Article  CAS  PubMed  Google Scholar 

  • Lazenka MF, Selley DE, Sim-Selley LJ. ΔFosB induction correlates inversely with CB1 receptor desensitization in a brain region-dependent manner following repeated Δ9-THC administration. Neuropharmacology. 2014;77:224–33.

    Article  CAS  PubMed  Google Scholar 

  • Lazenka MF, Tomarchio AJ, Lichtman AH, Greengard P, Flajolet M, Selley DE, et al. Role of dopamine type 1 receptors and dopamine- and cAMP-regulated phosphoprotein Mr 32 kDa in Δ9-tetrahydrocannabinol-mediated induction of ΔFosB in the mouse forebrain. J Pharmacol Exp Ther. 2015;354(3):316–27.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Li SC, Passow S, Nietfeld W, Schröder J, Bertram L, Heekeren HR, et al. Dopamine modulates attentional control of auditory perception: DARPP-32 (PPP1R1B) genotype effects on behavior and cortical evoked potentials. Neuropsychologia. 2013;51(8):1649–61.

    Article  PubMed  Google Scholar 

  • Li L, Gervasi N, Girault J-A. Dendritic geometry shapes neuronal cAMP signalling to the nucleus. Nat Commun. 2015;6:6319.

    Article  PubMed  CAS  Google Scholar 

  • Lindskog M, Svenningsson P, Pozzi L, Kim Y, Fienberg AA, Bibb JA, et al. Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine. Nature. 2002;418(6899):774–8.

    Article  CAS  PubMed  Google Scholar 

  • Mahajan SD, Aalinkeel R, Reynolds JL, Nair BB, Sykes DE, Hu Z, et al. Therapeutic Targeting of “DARPP-32”. A key signaling molecule in the dopiminergic pathway for the treatment of opiate addiction. Int Rev Neurobiol. 2009;88:199–222.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Meyer-lindenberg A, Straub RE, Lipska BK, Verchinski BA, Goldberg T, Callicott JH, et al. Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition. Health (San Francisco). 2007a;117(3):672–82.

    CAS  Google Scholar 

  • Meyer-Lindenberg A, Straub RE, Lipska BK, Verchinski BA, Goldberg T, Callicott JH, et al. Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition. J Clin Invest. 2007b;117(3):672–82.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Nairn AC, Svenningsson P, Nishi A, Fisone G, Girault JA, Greengard P. The role of DARPP-32 in the actions of drugs of abuse. Neuropharmacology. 2004;47:14–23.

    Article  CAS  PubMed  Google Scholar 

  • Reis HJ, Rosa DV, Guimarães MM, Souza BR, Barros AG, Pimenta FJ, et al. Is DARPP-32 a potential therapeutic target? Expert Opin Ther Targets. 2007;11(12):1649–61.

    Article  CAS  PubMed  Google Scholar 

  • Risinger FO, Freeman PA, Greengard P, Fienberg AA. Motivational effects of ethanol in DARPP-32 knock-out mice. J Neurosci Off J Soc Neurosci. 2001;21(1):340–8.

    Article  CAS  Google Scholar 

  • Robison AJ, Nestler EJ. Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci. 2011;12(11):623–37.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Rosa DVF, Souza RP, Souza BR, Motta BS, Caetano F, Jornada LK, et al. DARPP-32 expression in rat brain after electroconvulsive stimulation. Brain Res. 2007;1179(1):35–41.

    Article  CAS  PubMed  Google Scholar 

  • Rowland LM, Kontson K, West J, Edden RA, Zhu H, Wijtenburg SA, et al. In vivo measurements of glutamate, GABA, and NAAG in schizophrenia. Schizophr Bull. 2013;39(5):1096–104.

    Article  PubMed  Google Scholar 

  • Schuck NW, Frensch PA, Schjeide BMM, Schröder J, Bertram L, Li SC. Effects of aging and dopamine genotypes on the emergence of explicit memory during sequence learning. Neuropsychologia. 2013;51(13):2757–69.

    Article  PubMed  Google Scholar 

  • Shin SS, Bray ER, Dixon CE. Effects of nicotine administration on striatal dopamine signaling after traumatic brain injury in rats. J Neurotrauma. 2012;29(5):843–50.

    Article  PubMed  PubMed Central  Google Scholar 

  • Smith CT, Swift-Scanlan T, Boettiger CA. Genetic polymorphisms regulating dopamine signaling in the frontal cortex interact to affect target detection under high working memory load. J Cogn Neurosci. 2014;26(2):395–407.

    Article  PubMed  Google Scholar 

  • Souza BR, Souza RP, DVF R, Guimarães MM, Correa H, Romano-Silva MA. Dopaminergic intracellular signal integrating proteins: relevance to schizophrenia. Dialogues Clin Neurosci. 2006;8:95–100.

    PubMed  PubMed Central  Google Scholar 

  • Souza RP, Soares EC, Rosa DVF, Souza BR, Gomes KM, Valvassori SS, et al. Cerebral DARPP-32 expression after methylphenidate administration in young and adult rats. Int J Dev Neurosci. 2009;27(1):1–7.

    Article  CAS  PubMed  Google Scholar 

  • Souza BR, Torres KCL, Miranda DM, Motta BS, Scotti-Muzzi E, Guimarães MM, et al. Lack of effects of typical and atypical antipsychotics in DARPP-32 and NCS-1 levels in PC12 cells overexpressing NCS-1. J Negat Results Biomed. 2010;9:4.

    Article  PubMed  PubMed Central  Google Scholar 

  • Svenningsson P. Diverse psychotomimetics act through a common signaling pathway. Science. 2003;302(5649):1412–5.

    Article  PubMed  CAS  Google Scholar 

  • Svenningsson P, Fienberg AA, Allen PB, Moine CL, Lindskog M, Fisone G, et al. Dopamine D(1) receptor-induced gene transcription is modulated by DARPP-32. J Neurochem. 2000a;75(1):248–57.

    Article  PubMed  CAS  Google Scholar 

  • Svenningsson P, Lindskog M, Ledent C, Parmentier M, Greengard P, Fredholm BB, et al. Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proc Natl Acad Sci U S A. 2000b;97(4):1856–60.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Svenningsson P, Nishi A, Fisone G, Girault J-A, Nairn AC, Greengard P. DARPP-32: an integrator of neurotransmission. Annu Rev Pharmacol Toxicol. 2004;44:269–96.

    Article  PubMed  CAS  Google Scholar 

  • Svenningsson P, Nairn AC, Greengard P. DARPP-32 mediates the actions of multiple drugs of abuse. AAPS J. 2005;7(2):E353–60.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Torres KCL, Souza BR, Miranda DM, Nicolato R, Neves FS, Barros AGA, et al. The leukocytes expressing DARPP-32 are reduced in patients with schizophrenia and bipolar disorder. Prog Neuro-Psychopharmacol Biol Psychiatry. 2009;33(2):214–9.

    Article  CAS  Google Scholar 

  • Ubersax JA, Ferrell Jr JE. Mechanisms of specificity in protein phosphorylation. Nat Rev Mol Cell Biol. 2007;8(7):530–41.

    Article  PubMed  CAS  Google Scholar 

  • Ung CY, Teoh TC. The evolutionary strata of DARPP-32 tail implicates hierarchical functional expansion in higher vertebrates. J Biosci. 2014;39(3):493–504.

    Article  PubMed  CAS  Google Scholar 

  • Vangamudi B, Peng D-F, Cai Q, El-Rifai W, Zheng W, Belkhiri A. t-DARPP regulates phosphatidylinositol-3-kinase-dependent cell growth in breast cancer. Mol Cancer. 2010;9:240.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Volkow ND, Baler RD, Compton WM, Weiss SRB. Adverse health effects of marijuana use. N Engl J Med. 2014;370:2219–27.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • West AR, Grace AA. Opposite influences of endogenous dopamine D1 and D2 receptor activation on activity states and electrophysiological properties of striatal neurons: studies combining in vivo intracellular recordings and reverse microdialysis. J Neurosci. 2002;22(1):294–304.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Yamada K, Takahashi S, Karube F, Fujiyama F, Kobayashi K, Nishi A, et al. Neuronal circuits and physiological roles of the basal ganglia in terms of transmitters, receptors and related disorders. J Physiol Sci. 2016;66:435–46.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Yger M, Girault J-A. DARPP-32, Jack of All Trades… Master of Which? Front Behav Neurosci. 2011;5:56.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Zachariou V, Benoit-Marand M, Allen PB, Ingrassia P, Fienberg AA, Gonon F, et al. Reduction of cocaine place preference in mice lacking the protein phosphatase 1 inhibitors DARPP 32 or Inhibitor 1. Biol Psychiatry. 2002;51(8):612–20.

    Article  PubMed  CAS  Google Scholar 

  • Zhu S, Belkhiri A, El-Rifai W. DARPP-32 increases interactions between epidermal growth factor receptor and ERBB3 to promote tumor resistance to gefitinib. Gastroenterology. 2011;141(5):1738–48.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculdade de Medicina, Instituto Nacional de Ciência e Tecnologia – Medicina Molecular, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil

    Daniela V. Rosa, Luiz Alexandre V. Magno, Bruno R. Souza & Marco A. Romano-Silva

  2. Departamento de Fisiologia e Biofísica, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil

    Bruno R. Souza

Authors
  1. Daniela V. Rosa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luiz Alexandre V. Magno
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bruno R. Souza
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marco A. Romano-Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marco A. Romano-Silva .

Editor information

Editors and Affiliations

  1. Department of Molecular Science and Technology, Ajou University, Suwon, Korea

    Sangdun Choi

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Rosa, D.V., Magno, L.A.V., Souza, B.R., Romano-Silva, M.A. (2018). DARPP-32 (Ppp1r1b). In: Choi, S. (eds) Encyclopedia of Signaling Molecules. Springer, Cham. https://doi.org/10.1007/978-3-319-67199-4_557

Download citation

Publish with us

Policies and ethics

Search

Navigation